Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sanofi and Regeneron score asthma hit with dupilumab

Sanofi and Regeneron’s biotech drug dupilumab scored a hit in treating severe asthma, clinical trial data showed, raising competition in an expected multibillion-dollar market.

Read More »

Novartis posts a win, Roche a flop in skin cancer trials

Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer, while a rival treatment from Roche with slipping sales failed in a separate study with a similar patient group.

Read More »

After melanoma surgery, Bristol’s Opdivo offers new care standard

Bristol-Myers Squibb’s immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients who have had surgery to remove disease, researchers reported.

Read More »

AstraZeneca rebuilds cancer drug hopes with new lung data

Two AstraZeneca drugs tackling lung cancer in different ways delivered impressive clinical results on Saturday, helping the British group offset July 2017’s big clinical trial setback in the disease.

Read More »

Two industry veterans join Giant Creative/Strategy

Giant Creative/Strategy LLC hired two industry veterans: Aaron Sklar joined Giant as Vice President, Brand Experience, and Andrew Wint was appointed SVP, Technology.

Read More »

Roche blood test could help ‘personalize’ cancer immunotherapy

A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunotherapies.

Read More »

Merck’s immunotherapy, chemo mix shows extended lung cancer gains

Giving Merck & Co.’s immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clinical trial.

Read More »

Clovis Oncology Presents Comprehensive Dataset from Successful Phase 3 ARIEL3 Maintenance Treatment Trial of Rucaparib in Advanced Ovarian Cancer at ESMO 2017

Clovis Oncology Inc. announced the first presentation of a comprehensive dataset from the company’s Phase 3 ARIEL3 study of rucaparib at the 2017 European Society for Medical Oncology (ESMO) Congress in Madrid.

Read More »

U.S. FDA warns of problems with EpiPen manufacturing plant

A U.S. regulator told Pfizer Inc.’s Meridian Medical Technologies division, maker of the EpiPen injector device, that serious component and product failures have been associated with patient deaths and severe illness.

Read More »

New Mexico sues opioid drug manufacturers, distributors

New Mexico sued eight opioid manufacturers and wholesale distributors, becoming the latest state or local government to file a lawsuit seeking to hold corporations accountable for a national drug addiction epidemic.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom